Australia markets closed

Bioxyne Limited (BXN.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0210-0.0030 (-12.50%)
At close: 01:03PM AEDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
2,416
2,416
2,110
2,259
2,133
Cost of revenue
1,128
1,128
1,029
1,044
990.066
Gross profit
1,289
1,289
1,081
1,215
1,143
Operating expenses
Research development
-
-
89.726
130.243
85.869
Selling general and administrative
904.719
904.719
870.206
921.893
1,035
Total operating expenses
1,546
1,546
1,467
1,729
2,615
Operating income or loss
-257.62
-257.62
-385.368
-514.196
-1,473
Interest expense
7.032
0.582
1.684
7.032
-
Total other income/expenses net
-43.755
-43.755
-94.703
-111.934
165.834
Income before tax
-236.508
-236.508
-425.725
-593.095
-1,266
Income tax expense
0
0
0
0
0
Income from continuing operations
-236.508
-236.508
-425.725
-593.095
-1,266
Net income
-236.508
-236.508
-425.725
-593.095
-1,266
Net income available to common shareholders
-236.508
-236.508
-425.725
-593.095
-1,266
Basic EPS
-
-0.00
-0.00
-0.00
-0.00
Diluted EPS
-
-0.00
-0.00
-0.00
-0.00
Basic average shares
-
640,145
640,145
640,145
640,145
Diluted average shares
-
640,145
640,145
640,145
640,145
EBITDA
-
-185.872
-336.777
-513.995
-1,473